吳崇榮，治療肥胖症藥物之現況，台灣醫學雜誌，45：31-36，2002
林佩姍，腦室內注射腺核? 致效劑對於攝食行為與催產素神經元活性 之影響，中國醫藥學院，碩士論文，2001
郭清輝，瘦體素與體重，臨床醫學，45：321-3，2000a
郭清輝，肥胖症，臨床醫學，46：200-4，2000b
劉佳宜，腺核? 對於下視丘與腦幹神經元活性的影響：自由進食與食 物剝奪大白鼠之比較，中國醫藥學院，碩士論文，2000
Anand BK., Brobeck JR. Hypothalamic control of food intake in rats and cats. Yale Journal of Biology＆ Medicine 24: 123-40. 1951.
Anderson R., Sheehan MJ., Strong P. Characterization of the adenosine receptors mediating hypothermia in the conscious mouse. British Journal of Pharmacology. 113: 1386-90, 1994.
Aoki C., Pickel VM. Neuropeptide Y in the cortex and striatum.
ultrastructural distribution and coexistence with classical neurotransmitters and neuropeptides. Annals of the New York Academy of Sciences. 611: 186-205, 1990.
Aravich PF., Sladek CD. Vasopressin and glucoprivic-feeding behavior：a new perspective on an old peptide. Brain Research. 385: 245-52, 1986.
Balasubramaniam A. Neuropeptide Y family of hormones ：Receptor
Balasubramaniam A. Clinical potentials of neuropeptide Y family of hormones. The American Journal of Surgery. 183: 430-4, 2002.
Baskin DG., Breininger JF., Schwartz MW. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes. 48: 828-33, 1999.
Baynes J., Dominiczak MH. 醫學生物化學, 潘淑芬譯, 藝軒, 台北, 2001
Bergen HT., Mobbs CV. Ventromedial hypothalamic lesions produced by gold thioglucose do not impair induction of NPY mRNA in the arcuate nucleus by fasting. Brain Research.707: 266-71, 1996.
Bernardis LL., Bellinger LL. The lateral hypothalamic area revisited：
Ingestive behavior. Neurosicence and Biobehavior Review. 20: 189-287.
1996.
Billington CJ., Briggs JE., HarkerS., Grace M., Levine AS.
Neuropeptide Y in hypothalamic paraventricular nucleus ： A center coordinating energy metabolism. American Journal of Physiology. 266:
R1765-70, 1994.
Billington CJ., Briggs JE., Grace M., Levine AS. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism.
American Journal of Physiology. 260: R321-7, 1991.
Capogrossi MC., Francendese A., Digirolamo M. Suppression of food intake by adenosine and inosine. American Journal of Clinical
Cass WA., Zahniser NR. Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release. Journal of Neurochemistry. 57: 147-52, 1991.
Chance WT., Balasubramaniam A., Dayal R. Hypothalamic concentration and release of neuropeptide Y into the microdialysates is reduced in anorectic tumor-bearing rats. Life Sciences. 54: 1869-74, 1994.
Christofi FL., Zhang H., Yu JG., Guzman J., Xue J., Kim M., Wang YZ., Cooke HJ. Differential gene expression of adenosine A1, A2a, A2b, and A3
receptors in the human enteric nervous system. Journal of Comparative Neurology. 439: 46-64, 2001.
Clark JT., Kalra PS., Crowley WR., Kalra SP. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology.
155: 427-9, 1984.
Clark JT., Sahu A., Kalra PS., Balasubramaniam A., Kalra SP.
Neuropeptide Y-induced feeding behavior in female rats：comparison with human NPY（[Met17]NPY）, NPY analog（[norLeu4]NPY）and peptide YY. Regulatory Peptides. 17: 31-9, 1987.
Collis MG., Hourani SMO. Adenosine receptor subtypes. Trends in Pharmacological Sciences. 14: 360-6, 1994.
Cox JE., Sims JS. Ventromedial hypothalamic and paraventricular nucleus lesions damage a common system to produce hyperphagia.
Behavioural Brain Research. 28: 297-308, 1988.
Deuchars SA., Brooke RE. and Deuchars J. Adenosine A1 receptors reduce release from excitatory but not inhibitory synaptic inputs onto lateral horn neurons. Journal of Neuroscience. 21: 6308-20, 2001.
Devenpor L. Manes G. Thomas T. Mena S. Kem D. Knehans A.
Aldosterone and the mobilization of energy. Appetite. 8: 81-90, 1987.
Dryden S., Pickavance L., Frankish HM., Williams G. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese（fa/fa）Zucker rats. Brain Research. 690: 185-8, 1995a.
Dryden S., Wang Q., Frankish HM., Pickavance L., Williams G. The serotonin （ 5-HT） antagonist methysergide increases neuropeptide Y
（NPY）synthesis and secretion in the hypothalamus of the rat. Brain Research. 699: 12-8, 1995b.
Dube MG., Kalra PS,. Crowley WR., Kalra SP. Evidence of physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Research. 690: 275-8, 1995.
Egawa M., Yoshimatsu H., Bray G. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats.
American Journal of Physiology. 260: R328-34, 1991.
Erickson JC., Hollopeter C., Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274:
1704-7, 1996.
Fink JS., Weaver DR., Rivkees SA., Peterfreund RA., Pollack AE., Adler
selective coexpression with D2 dopamine receptors in rat striatum.
Molecular Brain Research. 14: 186-95, 1992.
Glass M., Faull RLM., Dragunow M. Localisation of the adenosine uptake site in the human brain: a comparison with the distribution of adenosine A1 receptors. Brain Research. 710: 79-91, 1996.
Glod RM. Hypothalamic obesity: The myth of the ventromedial nucleus.
Science. 182: 488-90, 1973.
Gunn I., O'Shea D., Bloom SR. Control of appetite-the role of
glucagon-like peptide-1 (7-36) amide. Journal of Endocrinology. 155:
197-200, 1997.
Haas DA., George SR. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity： lack of effect in other rat brain regions. Life Sciences. 41: 2725-31, 1987.
Heinrichs SC., Menzaghi F., Pich EM., Hauger RL., Koob GF.
Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Research. 611: 18-24, 1993.
Inui A. Neuropeptide Y feeding receptors-Are multiple subtypes involved?
Trends in Pharmacological Sciences 20: 43-46, 1999.
Inui A. Transgenic approach to the study of body weight regulation.
Pharmacological Reviews. 52: 35-55, 2000.
Ishihara A., Tanaka T., Kanatani A., Fukami T., Ihara M., Fukuroda T. A
intake in Zucker fatty rats. American Journal of Physiology. 274:
R1500-4, 1998.
Jain MR., Dube MG., Kalra SP., Kalra PS. Neuropeptide Y release in the paraventricular nucleus is decreased during transient hyperphagia induced by microinjection of colchicine into the ventromedial nucleus of rats.
Neuroscience Letters. 256: 21-4, 1998.
Kalra SP., Bube MG., Pu S., Xu B., Horvath TH., Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endorcrine Review. 20: 68-100, 1999.
Kalra PS., Bube MG., Xu B., Kalra SP. Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain. Regulatory Peptides. 72: 121-30, 1997.
Kanatani A., Ishihara A., Asahi S., Tanaka T., Ozaki S., Ihara M. A potent neuropeptide Y Y1 receptor antagonist, 1229U91 ： blockade of neuropeptide Y-induced and physiological food intake. Endocrinology.
137: 3177-82, 1996.
Lavoinne A., Buc HA., Claeyssens S., Pinosa M., Matray F. The mechanism by which adenosine decreases gluconegenesis from lactate in isolated rat hepatocytes. Biochemical Journal. 246: 449-54, 1987.
Leibowitz SF., Sladek C., Spencer L., Tempel D. Neuropetide Y, epinephrine, and norepinehrine in the paraventricular nucleus：stimulation of feeding and release of corticosterone, vasopressin, and glucose. Brain Research. 21: 905-12, 1988.
Levine AS., Morley JE. Purinergic regulation of food intake. Science. 217:
77-9,1982.
Levine AS., Morley JE. Effect of intraventricular adenosine on food intake in rats. Pharmacology Biochemistry＆ Behavior. 19: 23-6, 1983.
Levine AS., Grace M., Krahn DD., Billington CJ. The adenosine agonist N6-R-phenylisopyladnosine（ R-PIA） stimulates feeding in rat. Brain Research. 477: 280-5, 1989.
Linden J. Basic Neurochemistry，Raven Press，New York，1994.
Mally J., Stone TW. Potential role of adenosine antagonist therapy in pathological tremor disorder. Pharmocology and Therapeutics. 72:
243-50, 1996.
Michel M., Beck-Sickinger A., Cox H., Doods HN., Herzog H., Larhammar D., Quiroon R., Schwartz T., Westfall T. International of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacological Reviews. 50: 143-9, 1998.
Mills SE. Regulation of porcine adipocyte matabolism by insulin and adenosine. Journal of Animal Science. 77: 3201-7, 1999.
Paxinos G., Watson C. The rat brain stereotaxic coordinates，Academic Press，London，1986.
Beermann F., Brunner HR. Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor. Nature Medicine. 4: 722-6, 1998.
Polidori C., Ciccocioppo R., Regoli D., Massi M. Neuropeptide Y receptors mediating feeding in the rat: characterization with antagonists.
Peptides. 21: 29-35, 2000.
Poucher SM., Keddie JR., Brooks R., Shaw G.R., Mckillop D.
Pharmacodynamic of ZM 241385, a potent A2a adenosine receptor antagonist, after enteric administration in rat, cat and dog. Journal of Pharmacy＆Pharmacology. 48: 601-6, 1996.
Sahu A., Kalra SP. Neuropeptidergic regulation of feeding behavior, Neuropeptide Y. Trends in Endocrinology and Metabolism. 4: 217-24, 1993.
Schindler M., Harris CA., Hayes B., Papotti M., Humphrey PP.
Immunohistochemical localization of adenosine A1 receptors in human brain regions. Neuroscience Letters. 297: 211-5, 2001.
Sheriff S., Chance WT., Iqbal S., Rizvi TA., Xiao C., Kasckow JW., Balasubramaniam A. Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-induced feeding in rats.
Peptides. 24: 245-54, 2003.
Stricker-Krongrad A., Beck B., Burlet C. Enhanced feeding response to neuropeptide Y in hypothalamic neuropeptide Y-depleted rats. European Journal of Pharmacology. 295: 27-34, 1996.
Stricker-Krongrad A., Burlet C., Beck B. Behavioral deficits in monosodium glutamate rats：specific changes in the structure of feeding behavior. Life Sciences. 62: 2127-32, 1998.
Swanson LW., Sawchenko PE. Hypothalamic integratio: Organization of the paraventricular and supraoptic nuclei. Annual Review of Neuroscience.
6: 269-324, 1983.
Wang C., Mullet MA., Glass MJ., Billington CJ., Levine AS., Kotz CM.
Feeding inhibition by urocortin in the rat hypothalamic paraventricular nucleus. American Journal of Physiology. 280: R473-80, 2001.
Williams M. Purine nucleosides and nucleotides as central nervous system modulators. Adenosine as the prototypic paracrine neuroactive sudstance. Annals of the New York Academy of Sicience. 603: 93-107, 1990.
Zarjevski N., Cusin I., Vettor R., Rohner-Jeanrenaud F., Jeanrenaud B.
Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology.
133: 1753-8, 1993.
saline( 5ul ) 或
saline( 5ul ) CGS(1ug/5ul) 或 或 埋管 5ul saline 5ul saline 5ul saline NPY(10ug/5ul) CPA(10ug/5ul)
fasting 1hr 2hr 3hr. 4hr
day 1 day2 day 3 day4 day 5 5 分鐘後 記錄攝食量
圖一、腦室內注射神經胜? Y 對腺核? A1（CPA）或 A2a（CGS）接受器致效劑引起降低大白鼠攝食行為作用的影 響之流程圖。 攝食量紀錄時間。
day1 day5 1hr. 2hr. 3hr. 4hr. day6 day7 day8 day9 重複
埋管 ZM 5 分鐘後 紀錄攝食量 間隔 48 小時 ZM 或 或 DPCPX DPCPX
圖二、腦室內注射 1、5、10μg 腺核? A1（DPCPX）或 A2a（ZM）接受器拮抗劑對大白鼠食物攝取的影響之流程圖。
攝食量紀錄時間。
0
cunulated 1hr food intake( g )
saline+saline
cumulated 4h food intake ( g )
##
saline ; ＊p＜0.01；ns（not significant）。上圖為累積 1h 之攝 食量；下圖為累積 4h 之攝食量。
0
cumulated 1hr food intake ( g )
saline+saline
saline ; ＊p＜0.01；ns（not significant）。上圖為累積 1h 之攝
0 5 10 15 20 25 30
1 2 3 4
NPY level ( % area )
ARC PVN
saline CPA 1ug CPA 5ug CPA 10ug
圖五、腺核? 對神經胜 @Y 表現量的調節作用（n＝6-10）。
由腦室內注射 1、5、10μg CPA 或 saline 後，對弓形核
（ARC）、室旁核（PVN）之神經胜 @Y 含量之影響。各
0 10 20 30 40 50
1 2 3 4
NPY level ( % area )